Chronic Kidney Disease Treatment: Managing Comorbidities and Dialysis Options for Physicians

Chronic kidney disease (CKD) is a medical condition that affects millions of people worldwide, characterized by the progressive loss of kidney function. The treatment of CKD not only focuses on dialysis and kidney transplant, but also on managing associated comorbidities such as anemia, hypertension, and cardiovascular diseases. Choosing the appropriate treatment is crucial for improving patients' quality of life and prolonging their survival.
Diving Deeper into CKD Treatment
Managing CKD involves a multidisciplinary approach that encompasses everything from a low-protein diet to the choice between hemodialysis and peritoneal dialysis. Hemodialysis is the most commonly used method, but peritoneal dialysis offers a viable alternative for certain patients, allowing for greater flexibility and autonomy. The decision on when to initiate dialysis should be made through a shared decision-making process, considering the patient's preferences and expected quality of life [1].
Controlling comorbidities is essential in the treatment of CKD. Anemia is a common complication that requires careful management, including iron supplementation and the use of erythropoiesis-stimulating agents [2]. Additionally, managing blood pressure and volume is critical to reduce mortality and improve the quality of life for patients on dialysis [3].
Kidney transplant remains the best treatment option for many patients, offering significant improvements in survival and quality of life. However, barriers to access transplant, especially in vulnerable populations, continue to be a significant challenge [4].
Conclusions
The treatment of chronic kidney disease is complex and requires a comprehensive approach that addresses both renal replacement therapy and the management of comorbidities. The choice between hemodialysis, peritoneal dialysis, and kidney transplant should be personalized, taking into account the needs and preferences of the patient. Furthermore, controlling anemia, hypertension, and other comorbidities is fundamental to improving clinical outcomes and the quality of life for patients with CKD.
Referencias
- [1] End-Stage Renal Disease: Medical Management
- [2] Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
- [3] Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- [4] Epidemiology of end-stage kidney disease
Created 6/1/2025